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Abstract
Background In the majority of vertebrates, gametogenesis and gamete-release depend on the pulsatile
secretion of luteinizing hormone-releasing hormone (LHRH) from the hypothalamus. Studies attempting
to artificially stimulate ovulation and spermiation may benefit from mimicking the naturally episodic
secretion of LHRH by administering priming injections of a synthetic analogue (LHRHa). This study
investigated the impact of low-dose priming injections of LHRHa on gamete-release in the Australian
toadlet Pseudophryne guentheri. Methods Toadlets were administered a single dose of two micrograms
per. gram LHRHa without a priming injection (no priming), or preceded by one (one priming) or two (two
priming) injections of 0.4 micrograms per. gram LHRHa. Spermiation responses were evaluated at 3, 7
and 12 hrs post hormone administration (PA), and sperm number and viability were quantified using
fluorescent microscopy. Oocyte yields were evaluated by stripping females at 10-11 hrs PA. A sub-sample
of twenty eggs per female was then fertilised (with sperm obtained from testis macerates) and
fertilisation success determined. Results No priming induced the release of the highest number of
spermatozoa, with a step-wise decrease in the number of spermatozoa released in the one and two
priming treatments respectively. Peak sperm-release occurred at 12 hrs PA for all priming treatments and
there was no significant difference in sperm viability. Females in the control treatment failed to release
oocytes, while those administered an ovulatory dose without priming exhibited a poor ovulatory response.
The remaining two priming treatments (one and two priming) successfully induced 100% of females to
expel an entire clutch. Oocytes obtained from the no, or two priming treatments all failed to fertilise,
however oocytes obtained from the one priming treatment displayed an average fertilisation success of
97%. Conclusion Spermiation was most effectively induced in male P. guentheri by administering a single
injection of LHRHa without priming. In contrast, female P. guentheri failed to ovulate without priming. A
single priming injection induced the release of oocytes of high viability compared to oocytes obtained
from females in the two priming treatment which underwent a process of over-ripening.
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Abstract
Background: In the majority of vertebrates, gametogenesis and gamete-release depend on the pulsatile secretion
of luteinizing hormone-releasing hormone (LHRH) from the hypothalamus. Studies attempting to artificially
stimulate ovulation and spermiation may benefit from mimicking the naturally episodic secretion of LHRH by
administering priming injections of a synthetic analogue (LHRHa). This study investigated the impact of low-dose
priming injections of LHRHa on gamete-release in the Australian toadlet Pseudophryne guentheri.
Methods: Toadlets were administered a single dose of two micrograms per. gram LHRHa without a priming
injection (no priming), or preceded by one (one priming) or two (two priming) injections of 0.4 micrograms per.
gram LHRHa. Spermiation responses were evaluated at 3, 7 and 12 hrs post hormone administration (PA), and
sperm number and viability were quantified using fluorescent microscopy. Oocyte yields were evaluated by
stripping females at 10-11 hrs PA. A sub-sample of twenty eggs per female was then fertilised (with sperm
obtained from testis macerates) and fertilisation success determined.
Results: No priming induced the release of the highest number of spermatozoa, with a step-wise decrease in the
number of spermatozoa released in the one and two priming treatments respectively. Peak sperm-release occurred
at 12 hrs PA for all priming treatments and there was no significant difference in sperm viability. Females in the
control treatment failed to release oocytes, while those administered an ovulatory dose without priming exhibited a
poor ovulatory response. The remaining two priming treatments (one and two priming) successfully induced 100%
of females to expel an entire clutch. Oocytes obtained from the no, or two priming treatments all failed to fertilise,
however oocytes obtained from the one priming treatment displayed an average fertilisation success of 97%.
Conclusion: Spermiation was most effectively induced in male P. guentheri by administering a single injection of
LHRHa without priming. In contrast, female P. guentheri failed to ovulate without priming. A single priming
injection induced the release of oocytes of high viability compared to oocytes obtained from females in the two
priming treatment which underwent a process of over-ripening.

Background
Assisted Reproductive Technologies (ART), including
the hormonal induction of sperm-release (spermiation),
oocyte-release (ovulation) and in-vitro fertilisation, have
enormous potential to assist the propagation of the
worlds declining amphibian species [1,2]. The reliable
and efficient collection of fresh gametes (spermatozoa
Correspondence: Aimee.Silla@gmx.com
School of Animal Biology, The University of Western Australia, Perth, Australia

and oocytes) is a pivotal component of ART, and for
the purpose of species conservation, should be
attempted via non-invasive protocols that ensure the
survival of genetically viable individuals. The exogenous
hormones human chorionic gonadotropin (hCG) and
luteinizing hormone-releasing hormone (LHRH) have
been used to induce spermiation [3-10] and ovulation
[11-15] in live anurans for more than 70 years. The earliest anuran spermiation and ovulation induction
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protocols were developed as human pregnancy tests,
whereby detoxicated urine was injected into an adult
frog or toad and gamete-release monitored [3,11]. The
bioactive constituent of human pregnancy urine that
induced gamete-release in test animals was hCG [16].
Despite the historical use of hCG to successfully induce
gamete release in a small number of model species, the
use of synthetic LHRHa is largely replacing hCG as a
generally more effective and reliable alternative.
The decapeptide LHRH (also called gonadotropinreleasing hormone, or GnRH), produced by the
hypothalamus, is directly responsible for the synthesis
and release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary
[17]. Once released, circulating LH and FSH bind to target receptors on the gonads, which respond by secreting
sex steroids (such as estrogen, progesterone and testosterone) and inducing oogenesis and ovulation in adult
females, and spermatogenesis and spermiation in adult
males [17]. For the majority of vertebrates, normal
reproductive function is dependant on the pulsatile
secretion of LHRH, which precedes the release of discrete pulses of LH and FSH [17]. The pulsatile nature of
LHRH release is important because it allows the pituitary gonadotropes to be ‘primed’ and sensitized to
further stimulation [18]. Studies attempting to artificially
stimulate ovulation and spermiation may therefore benefit from mimicking the naturally episodic secretion of
LHRH via the use of priming injections.
Pulsatile administration of LHRH has proven to be
effective at stimulating ovulation in a variety of animals
including ungulates [19-22], marsupial mammals
[23,24], higher primates [25], and humans [26-28]. A
study by Rodger & Mate [23] on the Australian Brushtailed Possum (Trichosurus vulpecular) found the
administration of a single injection of synthetic LHRH
(3 days after the injection of pregnant mares’ serum
gonadotrophin, PMSG) to be ineffective at stimulating
ovulation. In contrast, administration of three low-dose
injections of LHRHa (spaced 90 mins apart, 3 days after
the injection PMSG) induced ovulation in a predictable
and reliable manner [23]. Similarly, the most effective
protocol found to stimulate ovulation in the Tammar
Wallaby (Macropus eugenii) was three low-dose LHRH
injections administered at 3 hr intervals (2-3 days after
PMSG)[24]. In amphibians the natural pulsatile release
of LHRH is yet to be quantified in vivo [17]. Despite
this, a recent study by Browne et al. [13] tested the
effectiveness of priming injections (administered at 3-4
day intervals prior to a higher ‘ovulatory’ dose) to
induce ovulation in the endangered Wyoming Toad
(Bufo baxteri). The administration of two low-dose
priming injections stimulated the release of a significantly greater number of oocytes with improved
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survivorship compared to those released following no
priming, or a single priming injection [13]. Whether the
use of priming injections similarly improves the ovulation response of other anuran species remains to be
determined.
Hormonal priming may also enhance the efficacy of
spermiation induction protocols. Most previous attempts
to induce spermiation in anurans have relied on a single
injection of LHRH [8-10,29], but there is limited evidence to suggest that multiple injections can improve
LH-release in vivo. A study on the American Bullfrog
(Rana catesbeiana) reported that the administration of a
second low-dose (0.4 μg) injection of LHRHa potentiated the release of LH following the initial injection of
equal dose [30]. In contrast, two LHRHa injections of
moderate dose (2 μg) desensitised the pituitary gland,
while the administration of two high doses (10 μg) of
LHRHa appeared to render the pituitary completely
refractory to the second injection [30]. These findings
suggest that multiple injections of LHRHa prime the
pituitary to further stimulation when administered at
low doses. Whether this increase in circulating LH corresponds to an increase in the number or viability of
sperm released is yet to be quantified in vivo.
To further investigate the impact of low-dose priming
injections on gamete-release, this study used the Western Australian anuran Pseudophryne guentheri, to: 1)
evaluate the effect of no, one and two priming injections
on the number of spermiating males, sperm count,
sperm viability and timing of sperm release; and 2) evaluate the effect of no, one and two priming injections on
the number of ovulating females, oocyte yield and fertilisation success.

Methods
The protocols described in this manuscript were performed following evaluation and approval by the University of Western Australia’s Animal Ethics Committee
(approval number RA/3/100/641 and RA/3/100/836).
Study species

Pseudophryne guentheri is a small (26-33 mm, snout-vent
length) terrestrial toadlet in the family Myobatrachidae. P.
guentheri is widely distributed throughout temperate forests and grasslands of south-western Australia. Breeding
activity commences in autumn following heavy rainfall
and continues until early winter. Male toadlets excavate
terrestrial burrows in moist soil along seasonally inundated drainage lines, swamps and depressions. Advertisement calls released by males attract females to the nest
site, where courtship occurs. During mating, the female
deposits 80-410 (mean = 224 ± 12 oocytes, n = 40, Silla
unpublished data) large, singly laid eggs which undergo
intracapsular embryonic development. Terrestrial
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embryonic development is suspended in its early stages
and larval development is later initiated when tadpoles
hatch in response to the flooding of the nest site following
winter rainfall. This reproductive mode (terrestrial
embryonic development, aquatic larvae) is shared with all
species in the genus Pseudophryne [31].
Animal collection and housing

The study animals were collected from a natural population located at Lake Pinjar, approximately 40 km north of
Perth, Western Australia. Male toadlets used for spermiation experiments were collected between 18:00 and 24:00
hrs from May 23-25 2009. Individual males were collected by tracking their vocalisations, locating the terrestrial nest and removing the resident animal by hand. The
male toadlets captured were observed broadcasting
advertisement calls and exhibited pigmented vocal sacs.
Female toadlets used for ovulation experiments were collected from May 13-28 2008. Female P. guentheri were
captured in pit-fall traps positioned within the breeding
chorus. Females displaying distended abdomens were
considered gravid (containing mature oocytes) and were
subsequently retained for use in this study.
Toadlets were transported to the laboratory where
they were housed individually in plastic aquaria (220
mm L × 140 mm W × 160 mm H) containing a layer of
moist sponge beneath a 10-12 cm deep soil layer, provided to allow burrowing. Toadlets were held in an artificially illuminated constant temperature room set to a
17°C day/12°C night temperature cycle and a 10.5/13.5
hr light/dark phase.
Experiment one: Hormonal induction of spermiation

The purpose of this experiment was to compare the
spermiation response of toadlets administered a single
spermiation dose of 2 μg/gram body weight LHRHa
(Leuprorelin acetate; Lucrin ® ) (no priming) to those
receiving a priming dose of 0.4 μg/gram body weight
LHRHa one hr prior to the administration of the spermiation dose (one priming), or two priming injections
of 0.4 μg/gram body weight LHRHa at one and two hrs
prior to the administration of the spermiation dose (two
priming)(Table 1). A spermiation dose of 2 μg/g was
selected as this has previously been identified as the
optimal dose to induce sperm-release in this species

[10]. Toadlets were randomly allocated to treatment
groups (n = 8 per treatment) and there were no significant differences (ANOVA: F3, 31 = 0.964, p = 0.424) in
the weight of animals in each treatment (n = 32, mean
mass (g) = 2.96 ± 0.07).
Hormones were diluted in 100 μL of Simplified
Amphibian Ringer (113 mM NaCl, 2 mM KCl, 1.35 mM
CaCl 2 , 1.2 mM NaHCO 3 ) and administered to P.
guentheri via subcutaneous injection into the dorsal
lymph sac. A control treatment consisted of toadlets
administered 100 μL of Simplified Amphibian Ringer
(SAR), which is the vehicle for hormone administration
(Table 1). Following hormone administration toadlets
were placed in holding tanks (50 mm D × 90 mm H)
containing three layers of sponge (20 mm W × 20 mm
L × 3 mm H) moistened with distilled water. Hydrating
each toadlet using this technique ensured that animals
could be stimulated to urinate at each sampling period.
Collection and assessment of spermic urine

Spermic urine was collected by gently inserting the end of
a glass microcapillary tube (fire polished and cooled) into
the cloaca to stimulate urination. Spermic urine was
sampled at 3, 7 & 12 hrs (± 10 mins) post hormone
administration. Once collected, spermic urine volume was
measured by placing the microcapillary tube (50 μL, 100
mm) alongside a ruler and dividing the length by two, providing the urine volume in microlitres. To assess sperm
viability, each spermic urine sample was homogenized
with 5 μL of a 1:50 dilution of the nucleic acid stain
SYBR-14 (Invitrogen L-7011) and incubated in the dark
for 7 mins. A 2 μL aliquot of Propidium iodide was then
added and the solution was incubated in the dark for a
further 7 mins. A wet mount was prepared and proportion
of viable sperm evaluated under a fluorescent microscope
at ×20 magnification and a wavelength of 490 nm. Spermatozoa fluorescing bright green were considered viable,
while those exhibiting red fluorescence were considered
non-viable. The total sperm count and proportion of
viable sperm per sample was determined by assessing the
sperm present in each urine sample in its entirety.
Experiment two: Hormonal induction of ovulation

Thirty-two female P. guentheri were randomly assigned
to one of four treatment groups (n = 8 per group), with

Table 1 Hormone injection protocol used to induce spermiation
Treatment

Dose administered at 0 hrs

Dose administered at 1 hr

Dose administered at 2 hrs

Control

-

-

0 μg/g LHRHa

No priming
One priming

-

0.4 μg/g LHRHa

2 μg/g LHRHa
2 μg/g LHRHa

Two priming

0.4 μg/g LHRHa

0.4 μg/g LHRHa

2 μg/g LHRHa

Hormone dose administered and timing of injections are shown for each priming treatment (n = 8/treatment).
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no significant differences (ANOVA: F3, 31 = 1.141, p =
0.350) in the weight of females between treatments (n =
32, mean mass (g) = 4.55 ± 0.14). The first treatment
group received a priming dose of 0.4 μg/gram body
weight LHRHa (Leuprorelin acetate; Lucrin®) at 20:00
hrs on day 0. Twenty-four hrs later females in this treatment group received a further priming dose of 0.4 μg/
gram body weight LHRHa, followed by a final ovulatory
dose of 2 μg/gram body weight LHRHa at 22:00 hrs on
day 3 (two priming treatment) (Table 2). The ‘one priming’ treatment received a single priming dose of 0.4 μg.
gram bodyweight-1 LHRHa, followed by a final ovulatory
dose of 2 μg/gram body weight LHRHa 26 hrs later.
The third treatment group received only a single dose of
2 μg/gram body weight LHRHa. Finally, a control group
consisted of 8 females injected with 100 μL of SAR
(Table 2). All hormone doses were diluted in 100 μL of
SAR and administered via subcutaneous injection into
the dorsal lymph sac. Following hormone administration
females were returned to their original aquaria.
Collection of oocytes and in-vitro fertilisation

Females from all treatments were removed from their
aquaria 10-11 hrs post administration of the ovulatory
dose and the expulsion of eggs from the oviduct was facilitated by holding the frog with legs unrestrained, and
gently applying pressure to the abdomen in a craniocaudal
direction (a technique referred to as stripping)[32].
Females that had ovulated expelled oocytes within 90 sec
of abdominal pressure being applied. Those females not
expelling oocytes at this time were returned to their aquaria and stripping was reattempted every 6-12 hrs for a period of 4 days; females that did not expel their oocytes at
10-11 hrs post hormone administration did not expel their
oocytes during the subsequent stripping attempts.
Oocytes from each female were collected in a dry Petri
dish and oocyte yield determined. Females were weighed
immediately prior to and post stripping and the average
egg mass per female was determined as delta mass/oocyte
yield. A subsample of twenty eggs per female were transferred to individual square trays (45 mm W × 45 mm L ×
8 mm H) and fertilised using sperm from previously prepared testis macerates obtained from field caught males.
To produce macerates males were killed by double-pithing
and both testes were thoroughly crushed in 250-600 μL of

SAR in eppendorf tubes and refrigerated at 5°C. The
sperm concentration in each suspension was measured
from a homogenized sub-sample using an Improved Neubauer Haemocytometer. Sperm suspensions were refrigerated for approximately 14 hrs before an aliquot was
activated in 1:4 SAR to yield a 200 μL solution with a fixed
concentration of 2500 sperm/μL. The sperm solution was
pipetted directly onto the oocytes and the tray was agitated for 1 min. Each tray was enclosed within a Petri-dish
and left to develop at room temperature (approx. 10-22°
C). Developing embryos were supplied with 100 μL of
deionised water at 30 mins, and a further 100 μL every 1224 hrs post fertilisation as required to maintain adequate
hydration. Fertilisation success was determined as the percentage of embryos developing to neurulation, Gosner
stages 14-16 [33].
Statistical Analyses

The number of spermiating and ovulating toadlets were
compared between LHRHa priming treatments (no, one
or two priming), and between each priming treatment
and the control, using two-tailed Fisher’s exact tests.
Brown-Forsythe tests were conducted on all variables to
determine homogeneity of variances prior to all other
analyses. Comparison of the number of spermatozoa
expelled over the 12 hr sampling period, and at individual
sampling times (3, 7 and 12 hrs PA) were analysed using
Welch’s ANOVAs due to unequal variances. Regression
analyses were conducted to determine whether the total
number of spermatozoa expelled could be predicted by
the volume of urine expelled, or toadlet mass. Sperm viability data was arcsine transformed using the transformation sin -1 (√x). Transformed sperm viability and
untransformed oocyte yield, oocyte mass and fertilisation
success were compared between priming treatments
using one-way analysis of variance (ANOVA) and TukeyKramer Honestly Significant Difference (HSD) post hoc
tests. All statistical analyses were performed using the
JMP 8.0.2 software package (SAS Institute Inc. 2009). For
all tests in this study, P < 0.05 was considered significant.

Results
Experiment one: Hormonal induction of spermiation

Urine samples were collected from all individuals at
each sampling time (3, 7 & 12 hrs) post administration

Table 2 Hormone injection protocol used to induce ovulation
Treatment

Dose administered at 0 hrs

Dose administered at 24 hrs

Dose administered at 50 hrs

Control

-

-

0 μg/g LHRHa

No priming
One priming

-

0.4 μg/g LHRHa

2 μg/g LHRHa
2 μg/g LHRHa

Two priming

0.4 μg/g LHRHa

0.4 μg/g LHRHa

2 μg/g LHRHa

Hormone dose administered and timing of injections are shown for each priming treatment (n = 8/treatment).
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(PA), with a mean volume of 25.97 ± 2.65 μL per sample. The majority of samples obtained from control animals were aspermic, however 25% (2/8) of individuals
within this treatment released a small total number of
spermatozoa (< 17) over the sampling period. Of the
males administered no, one or two priming injections of
LHRHa, 100% (8/8) of samples contained spermatozoa
within three hrs of hormone treatment and continued
to contain spermatozoa at 12 hrs PA. The number of
spermiating males was significantly higher in priming
treatments (8/8) relative to the control treatment (2/8;
two-tailed Fisher Exact Tests, p = 0.007), but the number of spermiating males administered no, one or two
priming injections of LHRHa (8/8) did not differ significantly from one another (two-tailed Fisher Exact Tests,
p = 1.00).
The total number of spermatozoa expelled over the 12
hr sampling period differed significantly according to
priming treatment (Welch’s ANOVA, F3, 11.667 = 9.255,
p = 0.002; Figure 1). The no priming treatment produced a significantly higher number of spermatozoa
compared to the control and two priming treatments
(Tukey-Kramer HSD, P < 0.05; Figure 1), but was not
significantly higher than the one priming treatment due
to high variance in the number of spermatozoa expelled
(Tukey-Kramer HSD, P > 0.05; Figure 1). In addition,
significant treatment effects were detected at each of the
individual sampling times, 3 hrs (Welch’s ANOVA, F3,
11.667 = 5.538, p = 0.013), 7 hrs (Welch’s ANOVA, F 3,
11.667 = 4.707, p = 0.022) and 12 hrs (Welch’s ANOVA,
F3, 11.667 = 5.270, p = 0.016) PA. The number of spermatozoa expelled by males in the no priming treatment
was consistently higher than the remaining treatments

Figure 1 The total number of spermatozoa (mean ± SEM)
released by frogs over a 12 hr period in response to
administration of control, no, one or two priming injections (n
= 8/treatment). Data shown are mean ± SEM. Letters displayed are
the result of a Tukey Kramer HSD post-hoc test, treatments that
share a letter are not significantly different from each other.
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at all sampling periods PA (Table 3). Peak sperm-release
occurred at 12 hrs PA for all priming treatments (Table
3). The total number of spermatozoa expelled was not
predicted by the volume of urine collected or toadlet
mass (r 2 < 0.001, p = 0.956; r 2 = 0.007, p = 0.645,
respectively).
The proportion of viable sperm (sperm viability) was
calculated for all samples where a sperm count of ≥ 30
spermatozoa was achieved. The overall mean sperm viability of spermatozoa collected from males administered
no, one or two priming injections of LHRHa (0.538 ±
0.057; 0.644 ± 0.048; 0.568 ± 0.036, respectively) did not
differ significantly from one another (one-way ANOVA,
F2,23 = 1.348, p = 0.281). Similarly, the sperm viability of
spermatozoa collected at each of the individual sampling
times (3, 7, and 12 hrs PA) did not differ significantly
(one-way ANOVAs, p > 0.05), despite the one priming
treatment inducing the expulsion of spermatozoa of
consistently higher viability. The temporal effect of sampling period (3, 7 & 12 hrs) on sperm viability affected
all priming treatments consistently. Maximal sperm viability occurred at 3 hrs PA, with an 8.42-18.49% drop in
sperm viability at 7 hrs PA, followed by a 5.19-11.38%
rise in sperm viability at 12 hrs PA (Table 3).
Experiment two: Hormonal induction of ovulation

Oocytes could not be stripped from all females administered a control injection of SAR, while females administered an ovulatory dose of LHRHa with no priming
injection, exhibited a poor ovulatory response (2/8). The
remaining two priming treatments (one and two priming) successfully induced 100% of females (8/8) to expel
oocytes when stripped at 10-11 hrs PA and this number
was significantly higher than the control and no priming
treatments (two-tailed Fisher Exact Tests, p < 0.05;
Table 4).
The total number of oocytes expelled (oocyte yield)
differed significantly according to priming treatment
(one-way ANOVA, F3,31 = 52.219, p < 0.001). The one
priming treatment resulted in the expulsion of a significantly greater number of oocytes compared to the control or no priming treatments (Tukey-Kramer HSD, P <
0.05; Table 5), but this was not significantly different to
the number of oocytes expelled from females in the two
priming treatment (Tukey-Kramer HSD, P > 0.05; Table
5). The mean mass (g) of oocytes obtained from females
administered no, one or two priming injections of
LHRHa (0.0011 ± 0.0016; 0.0059 ± 0.0012; 0.0073 ±
0.0007, respectively), differed significantly according to
priming treatment (one-way ANOVA, F2,17 = 4.108, p =
0.038). The oocytes obtained from females receiving an
ovulatory dose of LHRHa without priming, were significantly smaller than those obtained from females receiving two priming injections (Tukey-Kramer HSD, P <
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Table 3 The number of spermatozoa released (× 103) and sperm viability of samples collected at 3, 7 and 12 hrs post
LHRHa administration
3 hrs PA

7 hrs PA

12 hrs PA

Treatment

Sperm Count (× 103)

Sperm Viability

Sperm Count (× 103)

Sperm Viability

Sperm Count (× 103)

Control

0.002 ± 0.002

-

0.0003 ± 0.0003

-

0.001 ± 0.001

-

No priming
One priming

4.157 ± 1.754
2.144 ± 1.061

0.558 ± 0.058
0.703 ± 0.074

5.289 ± 2.826
1.762 ± 0.854

0.511 ± 0.093
0.573 ± 0.125

8.609 ± 3.153
2.807 ± 1.159

0.540 ± 0.069
0.653 ± 0.060

Two priming

0.525 ± 0.176

0.595 ± 0.104

0.962 ± 0.341

0.530 ± 0.079

1.813 ± 0.874

0.570 ± 0.064

Sperm Viability

Sperm viability was calculated as live sperm/total. n = 8/treatment. Data shown are means ± SEM.

0.05; Table 5), with oocytes obtained from a single
priming injection of intermediate mass (Tukey-Kramer
HSD, P > 0.05; Table 5). A random subset of twenty
expelled oocytes per female were fertilised and the proportion developing to neurulation (fertilisation success)
assessed. The mean fertilisation success of oocytes collected from females administered no, one or two priming injections differed significantly (one-way ANOVA,
F 2,17 = 773.83, p < 0.001). Oocytes collected from
females in the one priming treatment exhibited high fertilisation rates ranging from 91-100%, while all oocytes
obtained from females in the no and two priming treatments failed to fertilise (Table 5).

Discussion
Few studies of anuran ART have attempted to induce
gamete-release by administering priming injections of
synthetic LHRH, an administration protocol that aims
to mimic the naturally episodic release patterns of this
hormone from the hypothalamus. This study quantified
the effect of no, one, or two priming injections of
LHRHa on the number of spermiating individuals,
sperm count, sperm viability and timing of spermrelease of male P. guentheri. Additionally, the ovulatory
response of female P. guentheri administered no, one, or
two priming injections of LHRHa was quantified by
determining the number of ovulating females, oocyte
yield and fertilisation success. The effects of low-dose
priming injections on spermiation and ovulation are discussed separately.
Hormonal induction of spermiation

All priming treatments illicited a spermiation response
in P. guentheri, with 100% of males administered

LHRHa releasing spermatozoa at each sampling period
(3, 7 & 12 hrs). The number of spermiating males, and
the sperm viability of spermic urine samples, did not
differ according to the number of priming injections
administered (no, one or two priming). This lack of difference in sperm viability among the three priming
treatments indicates that the hormone protocol used did
not stimulate the final stages of spermiogenesis, the process of elongation and transformation of spermatids into
mature viable spermatozoa [34]. Hormonal priming
injections may stimulate earlier stages of spermatogenesis, such as spermatogonium proliferation or the transformation of spermatocytes into spermatids [cf [34]],
however this would need to be investigated with histological examination of the testis, which was beyond the
scope of this study.
The number of spermatozoa expelled by males differed significantly according to priming treatment. Contrary to expectations, peak sperm-release occurred in
the no priming treatment, with a decrease in the number of spermatozoa expelled in the one priming treatment, and a further decline identified in the two
priming treatment. The observed decline in the number
of spermatozoa expelled may be the result of LHRHreceptor desensitisation and down-regulation, whereby
LHRH doses in excess of the optimal range induce a
decline in the number or sensitivity of LHRH-receptors,
reducing LH release, and subsequently impeding the
spermiation response [35]. For example, a study by
McCreery et al [30] on the American Bullfrog (Rana
catesbeiana) reported that the administration of two
LHRHa injections of moderate dose (2 μg) desensitised
the pituitary gland, while administration of a second
low-dose (0.4 μg) injection of LHRHa potentiated the

Table 4 Comparison of the number of ovulating females administered no, one or two priming injections of LHRHa (n
= ovulating females/females within treatment group)
Control (n = 0/8)
Control(n = 0/8)

No priming (n = 2/8)
0.467

No priming(n = 2/8)

0.467

One priming(n = 8/8)

0.0002*

0.007*

Two priming(n = 8/8)

0.0002*

0.007*

One priming (n = 8/8)

Two priming (n = 8/8)

0.0002*

0.0002*

0.007*

0.007*
1.000

1.000

Data shown are P values generated from two-tailed Fisher Exact Tests. * denotes statistical significance (P < 0.05).
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Table 5 The number of ovulating females, oocyte yield, oocyte mass and fertilisation success of oocytes obtained
from females administered no, one or two priming injections of LHRHa (n = 8/treatment)
Treatment

No. females expelling oocytes

Oocyte yield

Control

0

0.00 ± 0.00

a

Oocyte mass (g)
-

-

Fertilisation Success
-

-

No priming

2

18.75 ± 13.62

a

0.0011 ± 0.0016

a

0.00 ± 0.00

a

One priming
Two priming

8
8

217.50 ± 12.53
220.13 ± 27.97

b
b

0.0059 ± 0.0012
0.0073 ± 0.0007

ab
b

0.97 ± 0.01
0.00 ± 0.00

b
a

Fertilisation success was calculated as the proportion of embryos developing to neurulation. Data shown are mean ± SEM. Letters displayed are the result of
Tukey Kramer HSD post-hoc tests, treatments that share a letter are not significantly different from each other.

release of LH [30]. In the present study a single injection of 2 μg/g LHRHa was administered as this dose
was previously identified as the optimal spermiation
dose for P. guentheri [10]. This injection was preceded
by the administration of no, one or two priming injections of 0.4 μg/g LHRHa. It is possible that the cumulative dose of LHRHa administered (2.0, 2.4 or 2.8 μg/g)
led to pituitary desensitisation, resulting in the release of
a lower number of spermatozoa in the one and two
priming treatments respectively.
An alternative explanation for the observed decline in
spermatozoa output is an additive stress response to
multiple injections, due primarily to increased handling
and needle puncture. It is well established that the
handling and restraint of individuals causes physiological
stress in a variety of vertebrates [36-39]. The increase in
plasma corticosterone associated with stress inhibits
reproduction [40] by blocking the release of LHRH from
the hypothalamus [41]. More specifically, the process of
spermatogenesis, and the quality and quantity of spermatozoa spermiated, have been shown to decline in
response to elevated circulating corticosterone concentrations [42,43]. To determine whether corticosterone
levels increase in response to multiple injections, plasma
samples would need to be obtained and analysed via
radioimmunoassay (RIA) techniques. These techniques
may have limited application in small anurans, such as
P. guentheri, where the collection of sufficient blood
volumes are restricted. An alternate approach is the analysis of urinary and faecal metabolites using high performance liquid chromatography (HPLC), though
limitations in the sensitivity of this technique should
also be considered [cf [44,45]]. If corticosterone levels
are found to increase in response to multiple injections,
alternate hormone administration protocols aimed at
reducing stress, such as topical application or controlled-release implants may be implemented in order to
improve the spermiation response.
The majority of published studies inducing spermiation in anurans have used a single injection of hCG or
LHRHa to promote sperm-release [6,8-10,14,15]. Results
from this study confirm that a single injection of
LHRHa is more effective than multiple priming injections at stimulating spermiation in the terrestrial toadlet

P. guentheri. A single injection protocol is therefore
recommended for future sperm-release induction studies
in this species.
Hormonal induction of ovulation

Data from this experiment show clear differences in the
ovulatory responses of female P. guentheri administered
no, one or two priming injections of LHRHa. An ‘ovulatory’ dose of LHRHa administered without priming was
insufficient to stimulate ovulation in the majority of
females tested, with only two of eight females in this
treatment group releasing oocytes. The two females able
to be stripped of oocytes released a partial clutch (mean
= 18.75 ± 13.62) substantially smaller than the average
clutch size of the species (mean = 224 ± 12 oocytes, n =
40, Silla unpublished data) and not statistically different
from the number of oocytes obtained from control
females (0.00 ± 0.00). In contrast, all females administered one or two priming injections were able to be
stripped of an entire clutch (mean = 217.50 ± 12.53;
220.13 ± 27.97, respectively). These results are comparable to the observations of Browne et al.[13], where
female Bufo baxteri failed to ovulate without the administration of one or two priming injections. Similarly, the
protocol employed to stimulate ovulation in Xenopus
tropicalis involves administering a single priming injection to females prior to an ovulatory dose [46]. Combining the results of the present study, with those of
Browne et al. [13], indicate that in some anuran species
priming injections are necessary to sensitise the ovary
and ensure successful ovulation following the administration of the ovulatory dose.
Interestingly, oocytes obtained from females in the
two priming treatment could not be fertilised, while
those obtained from females in the one priming treatment exhibited consistently high fertilisation success
(0.97 ± 0.01). These results contrast with the observations of Browne et al. [13], where oocytes collected
from female Bufo baxteri administered two priming
injections displayed a significantly greater proportion of
embryos developing to neurulation than those from one
priming (0.13 ± 0.03; 0.06 ± 0.04, respectively). It is
important to note however, that overall the proportion
of embryos developing to neurulation reported by
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Browne et al. [13] were substantially lower than those
observed from the one priming treatment in the present
study (see above). A plausible explanation for the diminished fertilisation capacity of oocytes obtained from
females administered two priming injections in the present study, is oocyte over-ripening. Over-ripening is the
process of aging of the oocytes retained within the coelomic cavity of the female post ovulation [cf [47]]. Overripened oocytes are commonly reported in broodfish
that do not oviposit spontaneously in captivity [47] and
over-ripening is always associated with a substantial
decrease in egg viability [48,49]. The terrestrial toadlet
P. guentheri, as with other terrestrial myobatrachids,
does not usually oviposit spontaneously following hormonal induction of ovulation in captivity (pers obs).
Instead, physical stimulation of the oviduct through the
process of stripping is required to obtain oocytes in this
species. It is possible that females administered two
priming injections of LHRHa ovulated earlier, and subsequently retained their oocytes longer, than those
administered one priming injection, despite females in
all treatments being stripped at a standard 10-11 hrs
PA. This would lead to the over-ripening of oocytes in
the two priming treatment, as indicated by the loss of
fertilisation capacity (egg viability) and increase in the
wet mass of oocytes [49].

Conclusion
The administration of priming injections of synthetic
LHRH, an administration protocol that aimed to mimic
the naturally episodic release patterns of this hormone
from the hypothalamus, produced different results for
male and female P. guentheri. In male P. guentheri, a
single injection of LHRHa without priming was most
effective at stimulating spermiation. In contrast, female
P. guentheri failed to ovulate without priming, while a
single priming injection induced the release of oocytes
displaying high fertilisation success. The administration
of a second priming injection induced the release of
oocytes that had undergone a process of over-ripening
and loss of fertilisation capacity.
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